Email from head of diagnostics division. From back in

New Post Public Reply Private Reply Replies (2) Message Board
zoomboom
Email from head of diagnostics division. From back in April 2014

Gerald has asked that I answer your question regarding the timing to launch the LymPro assay under CLIA regs. If we partner with an existing clinical laboratory to implement and offer LymPro as a laboratory developed test (LDT), there is no formal application required. The test must be validated in the partner clinical lab and then the lab sends an updated test menu document to the appropriate regulatory body (state or federal, depending on the state in which the lab is located). The test menu would indicate that the lab is now offering the LymPro test. Once that is done the lab may offer LymPro.

The lab will need to have a complete development and validation package on file, as the CLIA inspector will usually ask to review it at the next scheduled inspection. If the inspector is satisfied with the documentation no further work is required.

The one exception to this process is New York State. NY conducts their own inspections of labs across the country and is known to be very thorough. Before a lab can offer LymPro in NY, the lab must submit an extensive package of documents to the New York State Department of Health. They will review the submission and inform the lab if the test is acceptable for NY. They may also conduct a site visit if they feel it is necessary.

In working with NY regulators over the past couple of years I’ve learned that they have a very large backlog and can take 6 to 12 months to approve a new LDT. However, after initial review of the submission they will often issue a provisional approval in 1 to 2 months. In any case, the only constraint arising from not having NY approval is that the lab may not accept samples from physicians in New York State.

I hope that has answered your question, let me know if you’d like more information.

Best regards,

Paul Jorgensen
Head of Diagnostics Product Development
Amarantus Bioscience

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LaserPecker Debuts U1: Innovations in UV Laser Engraving

Updated Category News Views 1

An Eye on the Future with LaserPecker's U1 This ain't your typical innovation announcement. LaserPecker is shifting the sands with their latest release, the U1, at IFA 2026 in Berlin. For anyone sick of struggling with transparent materials like glass and crystal, this thing promises to be a game-changer, boasting cutting-edge technology in UV laser engraving. While...

Continue Reading
TCL CSOT Dazzles IFA 2026 with Future Display Tech

Updated Category News Views 0

Breaking Ground in Display Technology Picture this: the bustling halls of IFA 2026 in Berlin, teeming with tech enthusiasts and industry leaders. Today marks the start of the grand event where TCL CSOT steps into the spotlight, unveiling a stunning array of next-gen display technologies under the APEX brand. This isn't just another tech show-and-tell; it's TCL’s bold...

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 1

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
AARP New York Promotes Affordable 'Staycation' Experiences

Updated Category News Views 2

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

Continue Reading
AI Data Retention: FastGPT’s Detailed Deletion Protocols

Updated Category News Views 2

In the world of AI-driven applications, data retention has become a hot potato, especially when we're talking about sensitive information like conversation records and audit logs. FastGPT, an open-source AI platform, has decided to tell it like it is by detailing exactly how these data pieces are retained and ultimately booted out. All this info was scattered to the winds...

Continue Reading
Ramaco Resources Faces Stock Shake-Up Amid Distribution

Updated Category News Views 0

Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...

Continue Reading
Art and Science Blend in Dr. De La Cruz's Approach

Updated Category News Views 2

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

Continue Reading
TECNO POVA 8 Pro 5G: Blending Speed with Style

Updated Category News Views 2

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 4

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 2

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading

Top 5 Most Recently Viewed Articles

LiveWorld Announces 2024 Financial Performance Highlights

Updated Category News Views 124

LiveWorld Financial Highlights for 2024 Today marks a significant moment for LiveWorld, Inc. as they unveil their financial results for the year 2024. The company, known for its commitment to enhancing digital customer engagement, has faced challenges typical of the current market landscape. A closer look at the financial highlights reveals the resilience and strategic...

Continue Reading
Discover the Incredible Growth of Ollie's Bargain Outlet Stock

Updated Category News Views 232

Understanding the Growth of Ollie's Bargain Outlet Stock Ollie's Bargain Outlet (NASDAQ: OLLI) has demonstrated remarkable resilience and impressive performance in the stock market over the past decade. This discount retailer has outperformed the broader market by an annualized rate of 10.39%, showcasing an average annual return of 23.52%. The company currently holds an...

Continue Reading
WiSA Technologies Unveils Innovative Audio Solutions at CES

Updated Category News Views 88

WiSA Technologies Introduces Groundbreaking Audio Innovations WiSA Technologies, Inc. (NASDAQ: WISA), is taking steps to transform the wireless audio landscape with its latest advancements showcased at CES 2025. The company, considering a rebranding to Datavault Inc., has introduced a range of new wireless audio technologies that promise to enhance home viewing...

Continue Reading
Elon Musk's X Platform Going Through Another Layoff Phase

Updated Category News Views 210

Recent Layoffs at Elon Musk's X Platform Elon Musk, the CEO of notable companies like Tesla and SpaceX, is witnessing another round of layoffs at his social media platform, formerly known as Twitter and now branded as X. This news has raised eyebrows once again, concerning the direction of the platform and its workforce stability. Details of the Layoffs Reports indicate...

Continue Reading
Alexandria Real Estate Equities Marks 32 Years of Innovation in Health

Updated Category News Views 216

Celebrating Over Three Decades of Leadership in Life Science Real Estate On a remarkable journey that began as a garage startup, Alexandria Real Estate Equities, Inc. (NYSE: ARE) has been at the forefront of developing innovative life science real estate for over thirty-two years. This milestone not only marks the company's anniversary but also highlights its pivotal role...

Continue Reading